View in EDS

An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.

Saved in:
Bibliographic Details
Title: An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.
Authors: Podder V; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA., Slomovitz BM; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA., Coleman RL; Texas Oncology, US Oncology Network, Georgetown, TX, USA.
Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2026 May 03, pp. 1-14. Date of Electronic Publication: 2026 May 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42059499
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Podder+V%22">Podder V</searchLink>; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA.<br /><searchLink fieldCode="AU" term="%22Slomovitz+BM%22">Slomovitz BM</searchLink>; Division of Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA.<br /><searchLink fieldCode="AU" term="%22Coleman+RL%22">Coleman RL</searchLink>; Texas Oncology, US Oncology Network, Georgetown, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101123358%22">Expert review of anticancer therapy</searchLink> [Expert Rev Anticancer Ther] 2026 May 03, pp. 1-14. <i>Date of Electronic Publication: </i>2026 May 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101123358 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8328 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737140%22">14737140 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Anticancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42059499
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14737140.2026.2665840
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Podder V
      – PersonEntity:
          Name:
            NameFull: Slomovitz BM
      – PersonEntity:
          Name:
            NameFull: Coleman RL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 05
              Text: 2026 May 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8328
          Titles:
            – TitleFull: Expert review of anticancer therapy
              Type: main
ResultId 1